{
    "sec_cik": "0000872589",
    "sec_company_name": "REGENERON PHARMACEUTICALS, INC. (Filer)",
    "document_type": "EX991",
    "sec_form_header": "Form 8-K",
    "sec_period_of_report": "20210111",
    "sec_filing_date": "20210111",
    "sec_changed_date": "20210111",
    "sec_accepted_date": "20210111060306",
    "sec_index_url": "https://www.sec.gov//Archives/edgar/data/872589/000110465921002614/0001104659-21-002614-index.htm",
    "sec_url": "https://www.sec.gov//Archives/edgar/data/872589/000110465921002614/0001104659-21-002614.txt",
    "metadata_file_name": "C:\Users\aaron\OneDrive\Desktop\homework\finance2\SEC-EDGAR-text\output_files_examples\batch_0010\003\REGN_0000872589_EX991_20210111_EX-99_metadata.json",
    "original_file_name": "",
    "original_file_size": "59524 chars",
    "document_group": "EX-99",
    "section_name": "EX-99",
    "section_n_characters": 38744,
    "endpoints": [
        "Exhibit 99.1 ",
        "RECONCILIATION OF GAAP NET INCOME TO NON - GAAP NET INCOME 38 REGENERON PHARMACEUTICALS, INC. RECONCILIATION OF GAAP NET INCOME TO NON - GAAP NET INCOME (Unaudited) (In millions, except per share data) 3;6HHVOLGH IRUDGGLWLRQDOLPSRUWDQWLQIRUPDWLRQUHJDUGLQJQRQ 6; *$$3ILQDQFLDOPHDVXUHVLQFOXGHGLQWKLVSUHVHQWDWLRQ"
    ],
    "extraction_method": "html",
    "warnings": [],
    "company_description": "REGN",
    "output_file": "C:\Users\aaron\OneDrive\Desktop\homework\finance2\SEC-EDGAR-text\output_files_examples\batch_0010\003\REGN_0000872589_EX991_20210111_EX-99_excerpt.txt",
    "time_elapsed": 0.0,
    "batch_number": 10,
    "batch_signature": "",
    "batch_start_time": "2023-04-16 23:51:33.991322",
    "batch_machine_id": "DESKTOP-BTCJU5K",
    "section_end_time": "2023-04-17 00:06:57.260739"
}